BA

BOEING COIndustrials

10-K for period ending 2025-12-31filed 2026-01-30accession 0001628280-26-004357filing on sec.gov ↗

answer key

field	SEC value	XBRL concept	printed on
Total revenue	$89.5B	Revenues	Total revenues
Operating income	$4.3B	OperatingIncomeLoss	Earnings/(loss) from operations
Net income attributable to the company	$2.2B	NetIncomeLoss	Net earnings/(loss) attributable to Boeing shareholders
Diluted EPS	$2.48	EarningsPerShareDiluted	Diluted earnings/(loss) per share
Cash and cash equivalents	$10.9B	CashAndCashEquivalentsAtCarryingValue	Cash and cash equivalents
Total assets	$168.2B	Assets	Total assets · Total liabilities and equity
Total liabilities	$162.8B	Liabilities	Total liabilities
Total shareholders' equity attributable to the company	$5.5B	StockholdersEquity	Total shareholders' equity/(deficit)
Net cash from operating activities	$1.1B	NetCashProvidedByUsedInOperatingActivities	Net cash provided/(used) by operating activities
Net cash from investing activities	$499.0M	NetCashProvidedByUsedInInvestingActivities	Net cash provided/(used) by investing activities
Net cash from financing activities	-$3.8B	NetCashProvidedByUsedInFinancingActivities	Net cash (used)/provided by financing activities

Income statement

table #30 · score 51 vs 32.5 runner-up · in millions

(Dollars in millions, except per share data)
Years ended December 31,	2025	2024	2023
Sales of products	75,356	53,227	65,581
Sales of services	14,107	13,290	12,213
Total revenues	89,463	66,517	77,794
Cost of products	(73,761)	(57,394)	(59,864)
Cost of services	(11,413)	(11,114)	(10,206)
Total costs and expenses	(85,174)	(68,508)	(70,070)
4,289	(1,991)	7,724
Income from operating investments, net	25	71	46
General and administrative expense	(6,090)	(5,021)	(5,168)
Research and development expense, net	(3,615)	(3,812)	(3,377)
Gain on dispositions, net	9,672	46	2
Earnings/(loss) from operations	4,281	(10,707)	(773)
Other income, net	1,125	1,222	1,227
Interest and debt expense	(2,771)	(2,725)	(2,459)
Earnings/(loss) before income taxes	2,635	(12,210)	(2,005)
Income tax (expense)/benefit	(397)	381	(237)
Net earnings/(loss)	2,238	(11,829)	(2,242)
Less: Net earnings/(loss) attributable to noncontrolling interest	3	(12)	(20)
Net earnings/(loss) attributable to Boeing shareholders	2,235	(11,817)	(2,222)
Less: Mandatory convertible preferred stock dividends accumulated during the period	345	58
Net earnings/(loss) attributable to Boeing common shareholders	1,890	(11,875)	(2,222)
Basic earnings/(loss) per share	2.49	(18.36)	(3.67)
Diluted earnings/(loss) per share	2.48	(18.36)	(3.67)

Balance sheet

table #32 · score 54.5 vs 17.8 runner-up · in millions

(Dollars in millions, except per share data)
December 31,	2025	2024
Assets
Cash and cash equivalents	10,921	13,801
Short-term and other investments	18,479	12,481
Accounts receivable, net	2,921	2,631
Unbilled receivables, net	9,158	8,363
Current portion of financing receivables, net	207
Inventories	84,679	87,550
Other current assets, net	2,301	2,965
Total current assets	128,459	127,998
Financing receivables and operating lease equipment, net	241	314
Property, plant and equipment, net	15,361	11,412
Goodwill	17,275	8,084
Acquired intangible assets, net	1,567	1,957
Deferred income taxes	107	185
Investments	1,048	999
Other assets, net of accumulated amortization of $1,014 and $1,085	4,177	5,414
Total assets	168,235	156,363
Liabilities and equity
Accounts payable	13,109	11,364
Accrued liabilities	27,141	24,103
Advances and progress billings	59,404	60,333
Short-term debt and current portion of long-term debt	8,461	1,278
Total current liabilities	108,115	97,078
Deferred income taxes	216	122
Accrued retiree health care	2,091	2,176
Accrued pension plan liability, net	4,287	5,997
Other long-term liabilities	2,432	2,318
Long-term debt	45,637	52,586
Total liabilities	162,778	160,277
Shareholders’ equity:
Mandatory convertible preferred stock, 6.00% Series A, par value $1.00 - 20,000,000 shares authorized; 5,750,000 shares issued; aggregate liquidation preference $5,750	6	6
Common stock, par value $5.00 - 1,200,000,000 shares authorized; 1,012,261,159 shares issued	5,061	5,061
Additional paid-in capital	21,441	18,964
Treasury stock, at cost	(28,029)	(32,386)
Retained earnings	17,252	15,362
Accumulated other comprehensive loss	(10,277)	(10,915)
Total shareholders' equity/(deficit)	5,454	(3,908)
Noncontrolling interests	3	(6)
Total equity	5,457	(3,914)
Total liabilities and equity	168,235	156,363

Cash flow statement

table #33 · score 55 vs 9.5 runner-up · in millions

(Dollars in millions)
Years ended December 31,	2025	2024	2023
Cash flows - operating activities:
Net earnings/(loss)	2,238	(11,829)	(2,242)
Adjustments to reconcile net earnings/(loss) to net cash provided/(used) by operating activities:
Non-cash items -
Share-based plans expense	426	407	690
Treasury shares issued for 401(k) contribution	1,530	1,601	1,515
Depreciation and amortization	1,953	1,836	1,861
Investment/asset impairment charges, net	45	112	46
Gain on dispositions, net	(9,672)	(46)	(2)
777X and 767 reach-forward losses	5,283	4,079
Other charges and credits, net	264	528	3
Changes in assets and liabilities -
Accounts receivable	(95)	(37)	(128)
Unbilled receivables	(677)	(60)	321
Advances and progress billings	(723)	4,069	3,365
Inventories	(1,501)	(12,353)	(1,681)
Other current assets	155	(16)	389
Accounts payable	724	(793)	1,672
Accrued liabilities	1,341	1,563	779
Income taxes receivable, payable and deferred	115	(567)	44
Other long-term liabilities	(346)	(329)	(313)
Pension and other postretirement plans	(593)	(959)	(1,049)
Financing receivables and operating lease equipment, net	274	512	571
Other	324	202	119
Net cash provided/(used) by operating activities	1,065	(12,080)	5,960
Cash flows - investing activities:
Payments to acquire property, plant and equipment	(2,942)	(2,230)	(1,527)
Proceeds from disposals of property, plant and equipment	82	49	27
Acquisitions, net of cash acquired	(1,248)	(50)	(70)
Proceeds from dispositions	10,585	124
Contributions to investments	(51,938)	(13,856)	(16,448)
Proceeds from investments	46,628	4,743	15,739
Supplier notes receivable	(662)	(694)	(162)
Repayments on supplier notes receivable	2	40
Purchase of distribution rights	(9)	(88)
Other	1	(11)	4
Net cash provided/(used) by investing activities	499	(11,973)	(2,437)
Cash flows - financing activities:
New borrowings	165	10,161	75
Debt repayments	(3,621)	(8,673)	(5,216)
Common stock issuance, net of issuance costs	18,200
Mandatory convertible preferred stock issuance, net of issuance costs	5,657
Stock options exercised	45
Employee taxes on certain share-based payment arrangements	(34)	(83)	(408)
Dividends paid on Mandatory convertible preferred stock	(331)
Other	58	(53)	17
Net cash (used)/provided by financing activities	(3,763)	25,209	(5,487)
Effect of exchange rate changes on cash and cash equivalents	40	(47)	30
Net (decrease)/increase in cash & cash equivalents, including restricted	(2,159)	1,109	(1,934)
Cash & cash equivalents, including restricted, at beginning of year	13,822	12,713	14,647
Cash & cash equivalents, including restricted, at end of year	11,663	13,822	12,713
Less restricted cash & cash equivalents, included in Investments	742	21	22
Cash and cash equivalents at end of year	10,921	13,801	12,691